CreativeOne Wealth LLC Acquires New Position in Addus HomeCare Co. (NASDAQ:ADUS)

CreativeOne Wealth LLC purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,668 shares of the company's stock, valued at approximately $887,000.

Other large investors also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare during the second quarter worth $31,000. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at $44,000. Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after acquiring an additional 366 shares in the last quarter. Finally, Sandia Investment Management LP acquired a new stake in shares of Addus HomeCare in the second quarter valued at $58,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Trading Up 1.3 %

NASDAQ:ADUS traded up $1.55 during trading hours on Friday, hitting $122.84. The company's stock had a trading volume of 63,892 shares, compared to its average volume of 131,280. The stock has a market capitalization of $2.23 billion, a P/E ratio of 28.11, a price-to-earnings-growth ratio of 2.12 and a beta of 1.04. The stock has a fifty day moving average of $127.30 and a 200-day moving average of $123.57. Addus HomeCare Co. has a 52-week low of $85.43 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.03 earnings per share. On average, sell-side analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,500 shares of company stock valued at $1,668,265. 4.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

ADUS has been the topic of several analyst reports. Oppenheimer increased their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a research note on Thursday, August 8th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Finally, Macquarie reiterated an "outperform" rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.